This HTML5 document contains 147 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46718223
rdf:type
wikibase:Item
schema:description
vědecký článek artikulong pang-agham 2005年学术文章 vedecký článok 2005年学术文章 επιστημονικό άρθρο teaduslik artikkel bilimsel makale სამეცნიერო სტატია artigo científico tieteellinen artikkeli scientific article published in October 2005 מאמר מדעי наукова стаття, опублікована в жовтні 2005 artículu científicu научни чланак 2005年學術文章 artykuł naukowy 2005年學術文章 مقالة علمية نشرت في أكتوبر 2005 2005年学术文章 artikull shkencor vitskapeleg artikkel научная статья 2005年学术文章 scienca artikolo artigo científico 2005 nî lūn-bûn articol științific videnskabelig artikel artigo científico 2005年學術文章 vetenskaplig artikel artículo científico publicado en 2005 บทความทางวิทยาศาสตร์ tudományos cikk article scientific 2005年学术文章 2005年學術文章 artikel ilmiah naučni članak 2005년 논문 article scientifique bài báo khoa học мақолаи илмӣ vitenskapelig artikkel научна статия scientific article published in October 2005 научни чланак articolo scientifico 2005年学术文章 article científic 2005年の論文 অক্টোবর ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ wetenschappelijk artikel wissenschaftlicher Artikel 2005年學術文章 scientific article published in October 2005
p:P577
wds:Q46718223-2DFC30E7-6ACE-4C2D-AADD-03726B34AF44
wdt:P577
2005-10-01T00:00:00Z
p:P407
wds:Q46718223-95F8E274-6795-4D8D-85DA-2D94B9B17FEB
wdt:P407
wd:Q1860
p:P2860
wds:Q46718223-318BE09A-51DE-47B0-8E42-BA803C72E64E wds:Q46718223-36EC32B1-4694-4E61-9A6B-1996A4DB2437 wds:Q46718223-4F693D49-BECF-4B6C-9CA5-A02B526ABDD4 wds:Q46718223-197C4237-7FA8-461E-90C6-EEB22F124FA3 wds:Q46718223-F2EEAD85-B354-471E-812D-5F5C455346E2 wds:Q46718223-B5EA3242-6651-4631-88E4-E44824E4D9E2 wds:Q46718223-B9AE24E6-DBDD-4166-AA27-B8281545E212 wds:Q46718223-C41F1390-D962-4A94-AC88-16EE112757CD wds:Q46718223-CEFCE11E-C4E0-4ADA-AFF9-53A2694EFC2F wds:Q46718223-E67E6E55-6FA9-44D7-85A7-A7D53FAF682A wds:Q46718223-E68A07CA-70C7-42C5-8205-6BE5C624FB1C wds:Q46718223-83AEB272-41CB-43CD-854B-C4C57DE3E311 wds:Q46718223-9D41DC97-C8AB-43A2-A1D5-66199826B6E5 wds:Q46718223-B3A31E4F-382F-4014-9BD7-EED92C33D744 wds:Q46718223-F1A785EC-5EBD-4713-A7F0-C39873DBFE5D wds:Q46718223-FDDB36D3-2DE7-4816-B37E-11B17B3C41D1 wds:Q46718223-6335A1A4-C894-4FF8-902D-F209C3FE070D wds:Q46718223-ABE035BB-C2D5-40B6-809E-10B3C8E18C3F
wdt:P2860
wd:Q42553131 wd:Q24669747 wd:Q34154888 wd:Q44958927 wd:Q44914021 wd:Q34755513 wd:Q41679681 wd:Q46697253 wd:Q42477394 wd:Q44876892 wd:Q44913920 wd:Q46414199 wd:Q43928996 wd:Q43792509 wd:Q28361611 wd:Q28361615 wd:Q45713746 wd:Q34346454
p:P2093
wds:Q46718223-CC53648C-0843-42C1-851F-0964E585E54A wds:Q46718223-8F1E3587-0CD5-48A6-92D1-A14B7ECEBADA wds:Q46718223-87C0B43E-7D12-4B1A-87CA-9D5A82B847B7 wds:Q46718223-75E44123-D2C0-4A68-B3FC-06561CE8DC19 wds:Q46718223-79505CF6-88A8-4DB3-96D5-D53B4BD2F086 wds:Q46718223-65AD54D3-A9F6-40CF-8239-FA4B0A7BCEAC wds:Q46718223-37855A7E-27CB-4A36-B5B0-51A784987BCD wds:Q46718223-FDAAE73F-4297-4ECA-9355-839B95FBA360
wdt:P2093
Stockbrügger RW Gilissen LP Engels LG van Gennip A Bos LP Hooymans PM Derijks LJ Bierau J
rdfs:label
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients
skos:prefLabel
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients
schema:name
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients
p:P1476
wds:Q46718223-27F5C895-D447-467C-9B3E-0ABE221270D8
wdt:P1476
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients
p:P304
wds:Q46718223-D01D7A4A-5B53-4C37-A39B-D1EB1771A266
wdt:P304
605-611
p:P31
wds:Q46718223-04D40712-D094-4112-802D-EE2A965BBFAC
wdt:P31
wd:Q13442814
p:P921
wds:Q46718223-9C7DD550-AADA-4BD4-B29B-B21210A7BC29 wds:Q46718223-5F83450D-A39C-4A3E-9401-803EE21CDCC5 wds:Q46718223-D45A49A6-F84C-445C-A649-32AFA3AC463D
wdt:P921
wd:Q418529 wd:Q917447 wd:Q101991
p:P698
wds:Q46718223-20DBE2E8-9847-46E0-A808-EE09DB14FCCF
wdtn:P698
n11:16181300
wdt:P698
16181300
p:P1433
wds:Q46718223-B372FDB0-44FF-4662-8EC1-D06FEAA5D9EF
wdt:P1433
wd:Q4726656
p:P433
wds:Q46718223-F8C5F8BD-D9E8-4825-B207-8F5DF5C31EA6
p:P478
wds:Q46718223-591B1887-2BD6-4F63-A49C-86E311109F98
wdt:P433
7
wdt:P478
22
p:P356
wds:Q46718223-41ADC54F-53F4-4D0B-88B1-F2F15E147DCA
wdtn:P356
n12:J.1365-2036.2005.02630.X
wdt:P356
10.1111/J.1365-2036.2005.02630.X
p:P5875
wds:Q46718223-C2170ED7-766B-4BDF-AE96-E4D093C27993
wdt:P5875
7583414